Showing results (21-30 of 70) with videos related to
Sort By:
Pageof 7
Anticancer Research|July 1, 1988
Mechanistic studies on N-benzyladriamycin-14-valerate (AD 198), a highly lipophilic alkyl adriamycin analogJ Lameh, L F Chuang, M Israel, et al.Cancer Research|June 1, 1989
Nucleoside uptake and membrane fluidity studies on N-trifluoroacetyladriamycin-14-O-hemiadipate-treated human leukemia and lymphoma cellsJ Lameh, R Y Chuang, M Israel, et al.Cancer Research|January 1, 1986
Interaction of three second-generation anthracyclines with polynucleotides, RNA, DNA, and nucleosomesL F Pearlman, R Y Chuang, M Israel, et al.In Vivo (Athens, Greece)|November 25, 1998
Suppression of chemokine-induced chemotaxis of monkey neutrophils and monocytes by chlorinated hydrocarbon insecticidesT Miyagi, K M Lam, L F Chuang, et al.DNA and Cell Biology|September 1, 1993
A simple method to distinguish between simian immunodeficiency virus isolates by restriction analysis of PCR productsD J Blackbourn, S Sutjipto, R H Doi, et al.Biochemical and Biophysical Research Communications|March 31, 1989
Cremophor EL, a widely used parenteral vehicle, is a potent inhibitor of protein kinase CF K Zhao, L F Chuang, M Israel, et al.Anticancer Research|January 1, 1989
Adriamycin interacts with diacylglycerol to inhibit human leukemia protein kinase CF K Zhao, L F Chuang, M Israel, et al.Biochemical Pharmacology|February 18, 1992
Activation of human leukemia protein kinase C by tumor promoters and its inhibition by N-trifluoroacetyladriamycin-14-valerate (AD 32)L F Chuang, H F Kung, M Israel, et al.Biochemical and Biophysical Research Communications|May 16, 1984
Selective inhibition of eukaryotic RNA polymerase: a possible new mechanism of antitumor drug actionL F Chuang, G N Nooteboom, M Israel, et al.Science (New York, N.Y.)|March 7, 1997
Requirement of the DEAD-Box protein ded1p for messenger RNA translationR Y Chuang, P L Weaver, Z Liu, et al.Pageof 7